Repligen Statistics
NASDAQ: RGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
163.81-6.48 (-3.81%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Repligen by the numbers
Repligen has a market capitalization of $10.47 billion based on 63.92M shares outstanding. With trailing EPS of $-0.21, Repligen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.5% below its 50-day average and 12.4% above its 200-day average.
Average daily trading volume is 1.17M shares, or about $191.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RGEN valuation vs. peer median
| Metric | RGEN | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.47B | $9.50B | +10% |
| Forward P/E | 61.8 | 25.0 | +148% |
| Avg. volume | 1.17M | 2.23M | -48% |
Peer median across 8 companies: HALO, QGEN, KYMR, TECH, KRYS, PCVX, CGON, TWST.
Valuation
- Market cap
- $10.47B
- Forward P/E
- 61.77
- Price / sales (latest FY)
- 14.18
- EPS (TTM)
- $-0.21
- Shares outstanding
- 63.92M
Price and trading
- Previous close
- 170.29
- Open
- 169.61
- Day range
- 162.50 – 169.61
- 52-week range
- 100.99 – 198.87
- 52-week change
- +0.80%
- 50-day moving average
- 177.16
- 200-day moving average
- 145.74
- Beta
- —
- Volume
- 697.68K
- Average volume
- 1.17M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 27, 2026
Additional statistics
- Market Cap
- 10.47B
- Forward Pe
- 61.77
- Eps
- -0.21
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 198.87
- Week52 Low
- 100.99
- Avg Volume
- 1.17M
- Shares Outstanding
- 63.92M
- Ma50
- 177.16
- Ma200
- 145.74
- Earnings Date
- Oct 27, 2026
- Pct From52w High
- -17.63%
- Pct From52w Low
- 62.20%